Enveric Biosciences announces issuance of U.S. patent [Yahoo! Finance]
Enveric Biosciences, Inc. (ENVB)
Company Research
Source: Yahoo! Finance
Derivatives” with claims to compositions and methods of treatment for novel molecules with the potential to be developed for mental health disorders. The ‘179 patent expands the protection of Enveric's pipeline of potentially neuroplastogenic and non-hallucinogenic molecules. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now See today's best-performing stocks on TipRanks Read More on ENVB: Disclaimer & Disclosure Report an Issue Enveric Biosciences files to sell 882,627 shares of common stock for holders Enveric Biosciences Secures $3.1M Through Warrant Exercise Enveric Biosciences trading resumes Enveric Biosciences announces exercise of warrants for $3.1M gross proceeds Enveric Biosciences trading halted, volatility
Show less
Read more
Impact Snapshot
Event Time:
ENVB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ENVB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ENVB alerts
High impacting Enveric Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
ENVB
News
- Enveric Biosciences Announces Patent IssuanceBusiness Wire
- Enveric Biosciences Announces Closing of Exercise of Warrants for $3.1 Million Gross ProceedsBusiness Wire
- Enveric Biosciences Announces Exercise of Warrants for $3.1 Million Gross ProceedsBusiness Wire
- Enveric Biosciences Receives Notice of Allowance for EVM301 Series of Drug CandidatesBusiness Wire
- Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 9th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2026”Business Wire
ENVB
Sec Filings
- 1/9/26 - Form 8-K
- 1/5/26 - Form SCHEDULE
- 12/31/25 - Form 424B3
- ENVB's page on the SEC website